A team at Children’s Hospital Los Angeles recently became the first in the world to use a novel, basket-shaped retrieval device to successfully remove a large right atrial thrombus (blood clot).
After 11 years spent in medical school, residency and fellowships, Elizabeth Chou, MD, a vascular surgeon who recently joined the Smidt Heart Institute at Cedars-Sinai, has earned her dream career. And she has no plans of stopping there. She’s on a path toward ensuring women in vascular surgery are represented—as incoming physicians and as patients.
Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no available therapies, today announced two upcoming poster presentations showing data on the company's lead clinical candidate, VS-041, a selective matrix metalloprotease (MMP) inhibitor for treatment of heart failure with preserved ejection fraction (HFpEF) and the discovery of novel calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) inhibitors for treatment of β-blocker resistant arrythmias, at the American Heart Association (AHA) Scientific Sessions November 5 – 7 in Chicago, IL.
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
Getting less than five hours of sleep in mid-to-late life could be linked to an increased risk of developing at least two chronic diseases, finds a new study led by UCL researchers.
Currently, the U.S. leads western nations in infant mortality and cardiac birth defects are a leading cause. New research harnesses the power of AI to detect dangerous cardiac abnormalities prenatally. Resulting medical protocols implemented at birth in those at-risk could go a long way toward saving lives.
Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.
New York Institute of Technology's Center for Esports Medicine announces a research collaboration with GE Healthcare that seeks to analyze the lean body mass of competitive esport athletes and help establish the sport’s first body composition benchmarks.
Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023. Dr. Fuster will continue in his roles as Physician-in-Chief of The Mount Sinai Hospital and as the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai.
A large population-based study of patients with atrial fibrillation (AF) and valvular heart disease (VHD) found that use of apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of intracranial or gastrointestinal (GI) bleeding compared with rivaroxaban. The authors say clinicians should consider these findings when selecting anticoagulants in this patient population. The study is published in Annals of Internal Medicine.
For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.
Due to longstanding systemic inequities, Hispanic and Black adults are generally less satisfied with their interaction with physicians and may not receive the same quality of care.
Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine, and founder and co-medical director of the Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute, passed away Friday, Oct. 7. He was 76.
The statistically and clinically significant results of the pilot program– one of the first in the country – showed that enrollment in Ochsner Digital Medicine brought nearly half of all out-of-control Hypertension patients under control at only 90 days.
Levels of the immune protein suPAR are high in patients with heart failure and predict both heart failure and death, a new study suggests. Beyond that, when suPAR is combined with BNP, a downstream indicator of heart failure, the ability to predict such risks gets even stronger.
A study by UChicago researchers identifies the role that the BNIP3 protein plays in the development of fatty liver and liver cancer.
The October issue of SLAS Discovery is now available open access on ScienceDirect.
Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
For the approximately 8.5 million people in the U.S. living with peripheral artery disease (PAD – pronounced P-A-D), which is narrowed or clogged arteries in the legs, treatment decisions and criteria for success should be led by their symptoms and self-reported quality of life, according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation.
Global health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill, say two leading cardiologists in a commentary published in The Lancet.
Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously prescribed medications.
A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main contributors to death and poor outcomes for critically ill COVID-19 patients. Researchers say the findings reinforce COVID-19 as a pulmonary disease with multi-organ injury related to systemic inflammation. However, they conclude results should not minimize the fact that patients with cardiovascular disease are still at risk for death due to COVID-19, as they have a high burden of risk factors for the disease.
In 2015, published findings from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive blood pressure management reduced cardiovascular disease and lowered the risk of death. In 2019, results of the SPRINT MIND trial showed that lowering blood pressure also reduced the risk of mild cognitive impairment in older adults. Now, researchers from Wake Forest University School of Medicine have shown that while intensive blood pressure control was beneficial to SPRINT participants’ health during the trial, the benefits for cardiovascular mortality went away after approximately two years when protocols for blood pressure management were no longer being followed.
Using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common, chronic diseases, including diabetes, hypertension, obesity, and sleep apnea, Vanderbilt University Medical Center researchers report this week in the journal Nature Medicine.
Keki R. Balsara, MD, MBA, has been appointed surgical director of Heart Failure and Transplantation at MedStar Heart & Vascular Institute. Dr. Balsara, a renowned cardiothoracic surgeon, will lead the heart transplantation and mechanical circulatory support programs based at MedStar Washington Hospital Center in Washington, D.C.
University Hospitals in Cleveland has received national recognition for its care of patients with uncontrolled blood pressure, diabetes, heart disease, and stroke.
Electronic gaming can precipitate life-threatening cardiac arrhythmias in susceptible children whose predisposition may have been previously unrecognized, according to a new report in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier.
Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation. The study, published in Cell Reports Medicine, built on ongoing collaborative Cleveland Clinic research to support further investigation into metformin as a drug repurposing candidate. Researchers used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.
Scientists at the UNC School of Medicine have made a significant advance in the promising field of cellular reprogramming and organ regeneration, and the discovery could play a major role in future medicines to heal damaged hearts.
Wake Forest University School of Medicine has received a five-year, $30 million grant to test a novel rehabilitation program designed for older patients hospitalized for acute heart failure.
An exploratory study suggests that people who eat more foods with omega-3 fatty acids in midlife may have better thinking skills and even better brain structure than people who eat few foods with the fatty acids. The study is published in the October 5, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. Omega-3 fatty acids are found in fish such as salmon, sardines, lake trout and albacore tuna. They are also found in foods fortified with the fatty acids or supplements.
In a new study of younger heart attack victims in Ontario, Canada, researchers found that the healthcare system delivers high quality care for younger heart attack survivors; however, there are still disparities between men and women.
Particle radioactivity, a characteristic of air pollution that reflects the colorless, odorless gas radon found in fine particulate matter (PM2.5) air pollution, enhances PM2.5 toxicity and increases risk of death from cardiovascular disease, especially from heart attack or stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
“We are excited to open our 18th hospital in the Hackensack Meridian Health network. This new LTACH will provide numerous benefits to our patients, their families and our community, which will lead to optimizing patient outcomes,” said Robert Garrett, chief executive officer, Hackensack Meridian Health.
B-type procyanidins, made of catechin oligomers, are a class of polyphenols found abundantly in foods like cocoa, apples, grape seeds, and red wine.
The University of Chicago Medicine's heart transplant program is making history once again. The program's transplant survival rates and transplant wait times are not only the best in the country, but they're the best in the history of heart transplantation, according to an analysis of Scientific Registry of Transplant Recipients (SRTR) data.
Pioneering heart care is a tradition at Cedars-Sinai. It’s a tradition that took root in 1924, when Cedars-Sinai became home to the first electrocardiogram machine in Los Angeles.
Ser pionero en el cuidado del corazón es una tradición en Cedars-Sinai. Es una tradición que se arraigó en 1924, cuando Cedars-Sinai se convirtió en el hogar de la primera máquina de electrocardiograma en Los Ángeles.
In this population-based surveillance, the authors found that myocarditis/pericarditis 0 to 7 days after mRNA vaccination in persons aged 5 to 39 years occurred in approximately 1 in 200,000 doses after the first dose and 1 in 30,000 doses after second dose of the primary series, and 1 in 50,000 doses after the first booster. The incidence varied markedly by age and sex, however, with a disproportionate number of cases occurring in male persons, notably among adolescents after dose 2 and first boosters.
New research led by a Keele University professor has found that uncontrolled high blood pressure is the main cause of cardiovascular emergencies in the USA.
In one of the first studies to examine the relationship between different types of grain intake and premature coronary artery disease in the Middle East, researchers found a higher intake of refined grain was associated with an increased risk of premature coronary artery disease in an Iranian population, while eating whole grains was associated with reduced risk.
Women with severe preeclampsia (severe high blood pressure) during pregnancy may be treated with extended-release nifedipine, a blood pressure-lowering medicine, daily during the labor and delivery process, according to new research published today in Hypertension, an American Heart Association journal.
The American Heart Association® and the American Medical Association recognized 15 Loyola Medicine primary care practices for their commitment to achieving better blood pressure control by awarding them Gold Status though their national initiative, Target: BP™.
The National Institutes of Health (NIH) has awarded a $15.75 million contract to researchers led by Case Western Reserve and Duke universities to accelerate development of therapeutic devices that improve chronic medical conditions.
Cleveland: Findings from a Cleveland Clinic-led trial show that increasing the salt intake by mouth for patients who are hospitalized with heart failure undergoing aggressive diuretic therapy did not affect how much fluid they retain or their kidney function, indicating that salt intake for heart failure patients may not be as harmful as previously thought. Conversely, these new findings may challenge the common practice of salt restriction during hospital admission since that might not be as helpful.
New data validate the benefits of the BVA-100 diagnostic blood volume measurement test in reducing hospital length of stay (LOS) for heart failure (HF) patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world’s leading experts in heart failure.
New data validate the benefits of the BVA-100 blood volume measurement test for Medicare heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world’s leading experts in heart failure.
Here is a summary of the September research discoveries and faculty news from Cedars-Sinai.
Cedars-Sinai Guerin Children’s pediatric specialists will share their expertise and recent research findings at the American Academy of Pediatrics Annual Meeting, taking place Oct. 7-11 in Anaheim, California.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
